Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

11:16 AM ET 8-K
M&A Deal JLL Income Property Trust, Inc. ZIPTAX

JLL Income Property Trust Signs $90M M&A Deal with Worcester Distribution Center

JLL Income Property Trust acquired the Worcester Distribution Center, a 396,000-square-foot Class A industrial building in the Western Boston submarket, for approximately $90 million. The property is 100% leased to a single tenant and features specialized storage buildouts including refrigeration and automation. This acquisition increases the company's industrial portfolio to $2.7 billion, representing 39% of its total assets.

Value
$90M
Counterparty
Worcester Distribution Center
9:16 AM ET 8-K
M&A Deal Plum Acquisition Corp. IV PLMK

Plum Acquisition Corp. IV M&A Deal with Controlled Thermal Resources Holdings Inc.

Plum Acquisition Corp. IV provided a status update on its pending business combination with Controlled Thermal Resources (CTR), announcing agreements to convert approximately $245 million of CTR's debt into equity and PIPE financing upon closing. The restructuring is designed to simplify the capital structure and strengthen the balance sheet ahead of the combined company's expected Nasdaq listing in Q4 2026. The deal supports CTR's development of the Hell’s Kitchen geothermal power and critical minerals project.

Counterparty
Controlled Thermal Resources Holdings Inc.
9:16 AM ET 8-K
Clinical Trial Data Gain Therapeutics, Inc. GANX

Gain Therapeutics Clinical Trial Data

Gain Therapeutics presented 12-month open-label extension data from its Phase 1b study of rexaceract, showing stabilization of MDS-UPDRS motor scores in Parkinson’s disease patients. The data suggests disease-modifying potential as patients showed no clinically meaningful progression of motor symptoms over the one-year period. The company plans to submit a Phase 2 protocol to the FDA and initiate a Phase 2 trial in Q1 2027.

Term
12 months
9:01 AM ET 8-K
Regulatory Approval NovoCure Ltd NVCR

NovoCure Regulatory Approval

NovoCure received approval from Japan's Ministry of Health, Labour and Welfare for its Optune Pax device to treat adult patients with unresectable locally advanced pancreatic cancer. The approval was based on Phase 3 PANOVA-3 trial results showing statistically significant improvement in median overall survival. This marks a major commercial milestone for the company in Japan, where pancreatic cancer is the fourth leading cause of cancer death.

Counterparty
Ministry of Health, Labour and Welfare (MHLW)
9:01 AM ET 8-K
M&A Deal La Rosa Holdings Corp. SRTM

La Rosa Holdings M&A Deal with NVIDIA B300 GPUs

La Rosa Holdings acquired latest-generation NVIDIA B300 GPUs as part of a strategic pivot into AI infrastructure and leased them back to generate recurring revenue. Alongside the acquisition, the company appointed Chairman Nicholas Adler as CEO to lead a transformation that includes evaluating the divestiture of its legacy real estate operations.

Counterparty
NVIDIA B300 GPUs
Term
long-term
8:30 AM ET 8-K
Partnership Evolution Metals & Technologies Corp. EMAT

Evolution Metals & Technologies Partnership with VIVIFY Technology Corporation

Evolution Metals & Technologies (EMAT) signed a non-binding letter of intent with VIVIFY Technology to form a strategic energy collaboration. VIVIFY will serve as the primary hydrogen energy technology partner and infrastructure provider for EMAT's planned U.S. rare earth magnet campus. The partnership aims to provide behind-the-meter, near-zero-emission power to support power-intensive critical materials processing.

Counterparty
VIVIFY Technology Corporation
8:30 AM ET 8-K
M&A Deal Nsts Bancorp, Inc. NSTS

Nsts Bancorp Signs $73.7M M&A Deal with Brookfield Bancshares, Inc.

NSTS Bancorp, Inc. completed its merger with Brookfield Bancshares, Inc., with NSTS merging into Brookfield and its subsidiary bank becoming a wholly-owned subsidiary of Brookfield. Shareholders of NSTS received $14.31 per share in cash, representing an aggregate merger consideration of approximately $73.7 million. As a result of the transaction, NSTS common stock has been delisted from the Nasdaq Capital Market.

Value
$73.7M
Counterparty
Brookfield Bancshares, Inc.
8:21 AM ET 8-K
Capital Raise Banzai International, Inc. PARA

Banzai International Capital Raise

Banzai International entered into a subscription agreement with its CEO and Chairman, Joseph Davy, for the private placement of 115,965 shares of Class B Common Stock. The shares were sold at $0.70 per share for an aggregate cash purchase price of approximately $81,176. Following the transaction, Mr. Davy maintains a 25.6% voting interest in the company.

Counterparty
Joseph Davy
8:20 AM ET 8-K
M&A Deal Bnb Plus Corp. BNBX

Bnb Plus M&A Deal with Comstock Multichain Fund and KGPLA Holdings LLC

BNB Plus Corp. entered into a second amendment to its Registration Rights Agreement with holders of its registrable securities, including Comstock Multichain Fund and KGPLA Holdings LLC. The amendment removes the mandatory filing deadline for a resale registration statement and replaces it with a demand-based obligation, while also waiving any prior failures by the company to meet its registration obligations.

Counterparty
Comstock Multichain Fund and KGPLA Holdings LLC
8:16 AM ET 8-K
M&A Deal SpyGlass Pharma, Inc. SGP

SpyGlass Pharma Signs $13M M&A Deal with Advanced Vision Science, Inc.

SpyGlass Pharma acquired 100% of the equity of Advanced Vision Science, Inc. (AVS) from Santen Holdings US for approximately $13 million in cash. The deal secures internal manufacturing capacity for the intraocular lenses (IOL) used in SpyGlass's Phase 3 drug delivery system and includes a supply agreement to continue providing products to Santen in Japan.

Value
$13M
Counterparty
Advanced Vision Science, Inc.
8:11 AM ET 8-K
Clinical Trial Data Azitra, Inc. AZTR

Azitra Clinical Trial Data

Azitra, Inc. has completed Cohort 1 of its Phase 1/2 clinical trial for ATR-04, a live biotherapeutic candidate for treating skin rash associated with EGFR inhibitors. Following a safety review committee clearance, the company is proceeding to enroll approximately 24 patients in Cohort 2 to further evaluate safety, tolerability, and preliminary efficacy.

8:02 AM ET 8-K
Clinical Trial Data Evommune, Inc. EVMN

Evommune Clinical Trial Data

Evommune presented Phase 2a proof-of-concept data for EVO301 in patients with moderate-to-severe atopic dermatitis, showing a 55% mean reduction in EASI scores at Week 12 compared to 22% for placebo. The trial validated IL-18 inhibition as a novel therapeutic approach with a favorable safety profile, and the company plans to initiate a Phase 2b dose-ranging trial in mid-2027.

Counterparty
European Academy of Dermatology and Venereology (EADV)
8:01 AM ET 8-K
Divestiture Radnostix Inc INIS

Radnostix Divestiture to Nano Nuclear Energy Inc. for $13.5M

Radnostix Inc. entered into a definitive agreement to sell its depleted uranium deconversion and fluorine extraction assets, including an NRC license and related patents, to Nano Nuclear Energy Inc. for $13.5 million. The consideration consists of $9.5 million in cash and $4 million in Nano Nuclear restricted common stock, allowing Radnostix to focus on its core radioisotope technology segments.

Value
$13.5M
Counterparty
Nano Nuclear Energy Inc.
7:59 AM ET 8-K
Clinical Trial Data Nektar Therapeutics NKTR

Nektar Therapeutics Clinical Trial Data

Nektar Therapeutics announced long-term Phase 2b data for rezpegaldesleukin in patients with alopecia areata (REZOLVE-AA) and atopic dermatitis (REZOLVE-AD) at the EADV Congress 2026. The data demonstrated sustained hair regrowth and deepening of response even six months after treatment cessation, suggesting a differentiated regulatory T cell (Treg) mechanism compared to existing systemic therapies.

Earnings call
Oct 1, 2026, 3:00 PM ET
7:55 AM ET 8-K
M&A Deal Armada Acquisition Corp. II XRPNU

Armada Acquisition Corp. II M&A Deal with Ripple Labs Inc.

Armada Acquisition Corp. II shareholders approved the business combination with Ripple Labs Inc. and Pathfinder Digital Assets LLC at an extraordinary general meeting. The transaction involves a merger and domestication of the company from the Cayman Islands to Delaware, where it will be renamed Arrington Capital SPAC I Inc. Approximately 69% of the shares entitled to vote were represented at the meeting to approve the deal.

Counterparty
Ripple Labs Inc.
7:51 AM ET 8-K
Capital Raise Veritone, Inc. VERI

Veritone Capital Raise of $15M

Veritone, Inc. entered into a securities purchase agreement for a registered direct offering of 20,000,000 shares of common stock at an implied price of $0.75 per share. The company expects to raise $15.0 million in gross proceeds to repay or restructure convertible debt and for general corporate purposes. The offering is expected to close on or about October 2, 2026.

Value
$15M
7:46 AM ET 8-K
Capital Raise Brightline Interactive, Inc. BTLN

Brightline Interactive Capital Raise of $1.25M

Brightline Interactive closed a private investment in public equity (PIPE) raising $1.25 million in gross proceeds through the issuance of units of common stock and warrants. The financing was led by drone industry executive Dr. Allan Evans in his personal capacity to support the development of the SpatialCore Physical AI platform.

Value
$1.25M
Counterparty
Dr. Allan Evans
7:39 AM ET 8-K
Clinical Trial Data Monte Rosa Therapeutics, Inc. GLUE

Monte Rosa Therapeutics Clinical Trial Data

Monte Rosa Therapeutics announced positive Phase 1 results for MRT-8102, a NEK7-directed molecular glue degrader for inflammatory diseases. The GFORCE-1 study in 108 subjects showed 80-90% NEK7 degradation and normalization of key ASCVD pathogenic drivers with a favorable safety profile, supporting the planned initiation of multiple Phase 2 studies in coronary artery disease, gout, and hidradenitis suppurativa.

Earnings call
Oct 1, 2026, 8:00 AM ET
7:05 AM ET 8-K
Capacity Expansion Fervo Energy Co FRVO

Fervo Energy Capacity Expansion

Fervo Energy has achieved commercial operation at its first 33 MW GeoBlock at Cape Station in Utah, marking the world's first greenfield enhanced geothermal development to reach this milestone. The facility was built in 23 months and is now generating revenue under a power purchase agreement, with two additional Phase I GeoBlocks expected to go online by January 2027.

7:01 AM ET 8-K
Product Launch D-Wave Quantum Inc. QBTS

D-Wave Quantum Product Launch

D-Wave Quantum Inc. launched its gate-model quantum computing simulator beta program, a key milestone in its development roadmap for fault-tolerant quantum systems. The program provides early access to a simulator built on D-Wave's dual-rail superconducting technology to partners including BBVA and the Jülich Supercomputing Centre. This launch allows customers to experiment with error-aware programming ahead of the general availability of D-Wave's forthcoming gate-model hardware.

Counterparty
BBVA, FirstQFM, Florida Atlantic University (FAU) and the Jülich Supercomputing Centre (JSC)

“Quantum error correction is a defining challenge in the race to commercially useful gate-model quantum computing. By giving leading organizations early access to our simulator, we’re enabling them to explore a fundamentally more efficient approach to fault tolerance and the applications we expect it will unlock.”

Dr. Alan Baratz, CEO of D-Wave
7:01 AM ET 8-K
M&A Deal Sadot Group Inc. SDOT

Sadot Group Signs $7.45M M&A Deal with Softech Resources Limited

Sadot Group Inc. completed the acquisition of the AI-enabled commercial origination platform 'SalesIQ' from Hong Kong-based Softech Resources Limited for a total stated value of $7.45 million. The consideration consists of $300,000 in cash and $7.15 million in newly designated Series D and Series E Non-Voting Contingently Convertible Preferred Stock. The company intends to integrate SalesIQ with its existing TradeIQ and TradeOS platforms to enhance its commodity trading and risk management capabilities.

Value
$7.45M
Counterparty
SOFTECH RESOURCES LIMITED
7:00 AM ET 8-K
M&A Deal OpenWorld, Inc. OPNW

VerifyMe M&A Deal with Open World Ltd.

VerifyMe, Inc. has completed its business combination with Open World Ltd., a Cayman Islands company specializing in real-world asset tokenization. Following the merger, the combined company has been renamed OpenWorld, Inc. and will trade on the Nasdaq under the new ticker symbol 'OPNW' effective October 1, 2026.

Counterparty
Open World Ltd.

“At VerifyMe, our primary objective has always been to create market value for our shareholders, and this merger represents the clearest path to achieving that objective. With OpenWorld’s real-world asset tokenization capabilities, we can provide our shareholders direct exposure to a business with a far larger opportunity ahead than we could have pursued independently.”

Adam Stedham, former Chief Executive Officer of VerifyMe

“Tokenizing the cash flows of some of the world’s most dynamic businesses has the potential to dramatically shift how companies finance their operations and how investors access yield. We believe bringing OpenWorld’s platform to a broader set of investors as a publicly traded company is a significant milestone in the path to more accessible global markets.”

Matthew Shaw, Chief Executive Officer
7:00 AM ET 8-K
M&A Deal National Fuel Gas Co NFG

National Fuel Gas Signs $2.62B M&A Deal with CenterPoint Energy Resources Corp.

National Fuel Gas Company completed its $2.62 billion acquisition of CenterPoint Energy's Ohio natural gas utility business, Vectren Energy Delivery of Ohio, LLC. The purchase was funded with $1.42 billion in cash and a $1.20 billion promissory note, doubling the company's utility rate base and expanding its regulated footprint to approximately 1.1 million customers.

Value
$2.62B
Counterparty
CenterPoint Energy Resources Corp.
6:52 AM ET 8-K
Divestiture Centerpoint Energy Inc CNP

Centerpoint Energy Divestiture to National Fuel Gas Company for $2.62B

CenterPoint Energy completed the sale of its Ohio natural gas business, Vectren Energy Delivery of Ohio, LLC (VEDO), to National Fuel Gas Company for $2.62 billion. The consideration consists of $1.42 billion in cash and a $1.20 billion promissory note maturing in September 2027. Proceeds will be used to fund CenterPoint's $66.7 billion 10-year capital plan and support investments in its core regulated utility footprint.

Value
$2.62B
Counterparty
National Fuel Gas Company
6:38 AM ET 8-K
M&A Deal Joint Corp JYNT

Joint Signs $8M M&A Deal with The Joint Franchises Texas, Ltd.

The Joint Corp. entered into an Asset Purchase Agreement to reacquire regional development rights in the Texas region from several affiliated entities for $8.0 million in cash. The deal includes the termination of existing regional developer agreements covering 141 franchised clinics and provides for up to $2.0 million in additional performance-based consideration over two years.

Value
$8M
Counterparty
The Joint Franchises Texas, Ltd. (and affiliates)
6:31 AM ET 8-K
Partnership VisionWave Holdings, Inc. VWAV

VisionWave Holdings Partnership with Sadot Group Inc. Worth $7.81M

VisionWave Holdings and Sadot Group Inc. formed CMJV LLC, a 50/50 joint venture to manage rights and financing related to C.M. Composite Materials Ltd. (CM). VisionWave contributed $7.81 million in existing loan rights and acquisition options to the JV, while Sadot committed $7.81 million in cash to match those advances.

Value
$7.81M
Counterparty
Sadot Group Inc.
6:30 AM ET 8-K
Partnership Sadot Group Inc. SDOT

Sadot Group Partnership with VisionWave Holdings, Inc. Worth $7.81M

Sadot Group Inc. entered into a 50/50 joint venture with VisionWave Holdings, Inc. through a newly formed entity, CMJV LLC, to acquire a controlling interest in C.M. Composite Materials Ltd., an Israeli aerospace and defense manufacturer. Sadot committed to contribute $7.81 million in cash over twelve months and issued 250,000 shares of common stock to VisionWave as an entry premium for the partnership opportunity.

Value
$7.81M
Counterparty
VisionWave Holdings, Inc.
Term
12 months
6:30 AM ET 8-K
Capital Raise Brookfield Asset Management Ltd. BAM

Brookfield Asset Management Capital Raise of $2B

Brookfield Asset Management announced the final close of Oaktree’s inaugural Asset-Backed Finance Fund (ABF I) with $2 billion in total commitments. The fund reached its target raise with support from a globally diversified base of institutional investors, including sovereign wealth funds and U.S. public pension plans.

Value
$2B
Counterparty
Oaktree Asset-Backed Finance Fund
6:07 AM ET 8-K
M&A Deal Inseego Corp. INSG

Inseego Signs $20M M&A Deal with Nokia Solutions and Networks Oy

Inseego Corp. completed the acquisition of Nokia's fixed wireless access (FWA) business for a combination of 1,163,693 shares and warrants. Alongside the closing, Nokia made a $10 million cash investment in Inseego and committed an additional $10 million cash payment to support engineering interoperability. The deal is expected to double Inseego's revenue and expand its global footprint across Europe, the Middle East, and Asia.

Value
$20M
Counterparty
Nokia Solutions and Networks Oy
6:06 AM ET 8-K
M&A Deal Vylor Inc. VYLR

Vylor M&A Deal with Corteva, Inc.

Vylor Inc. provided a status update on its pending separation from parent company Corteva, Inc. into an independent, publicly traded company. Following a U.S. Court of Appeals ruling and a subsequent District Court denial of California's motion to enjoin the transaction, Corteva waived certain legal restraint conditions to proceed with the spin-off distribution. The separation is expected to be completed prior to 9:30 a.m. on October 1, 2026.

Counterparty
Corteva, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.